Nicolas Krink is co-founder and CEO of BioHalo, developing next-generation biomaterials to replace PFAS. Driven by a vision to create lasting impact, he has worked at the forefront of Synthetic Biology, from his thesis in Drew Endy's lab at Stanford to a PhD at the Max Planck Institute.

He co-founded Germany's grassroots SynBio network GASB and held roles at BlueYard Capital and SPRIND. His work bridges cutting-edge research and real-world applications to drive sustainable innovation.